Neoadjuvant chemoradiotherapy followed by resection for esophageal cancer: clinical outcomes with the 'CROSS-regimen' in daily practice.

Autor: Cloos-V Balen M; Department of Medical Oncology, Leiden University Medical Center and Groene Hart Ziekenhuis Gouda, Gouda, the Netherlands., Portier ESH; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands., Fiocco M; Department of Biomedical Science, Medical Statistical Section, Leiden University Medical Center, Leiden, the Netherlands., Hartgrink HH; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands., Langers AMJ; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands., Neelis KJ; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands., Lips IM; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands., Peters FP; Department of Radiation Oncology, Leiden University Medical Center and The Netherlands Cancer Institute, Leiden, the Netherlands., Slingerland M; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.

Publikováno v: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus [Dis Esophagus] 2022 Apr 19; Vol. 35 (4).